Delivery Order SPE2DR25D1104-SPE2DR26FK292
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $2,372.92 to AmerisourceBergen Drug Corp for the supply of NovoLog 100 Unit/mL vials (10 mL) on June 18, 2025, with an ultimate completion date of June 20, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded through open procurement. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters and...
- The Defense Logistics Agency awarded a $11,027.66 firm fixed-price delivery order to AmerisourceBergen Drug Corp for NovoLog 100 Unit/mL vials (10 mL) with an ultimate completion date of September 24, 2025. This non-set-aside contract was competitively awarded and represents a single delivery order under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical. The pharmaceutical product will be delivered to AmerisourceBergen's distribution facility in Conshohocken,...
- The Defense Logistics Agency awarded a $3,362.46 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 18, 2025, for the supply of NovoLog 100 Unit/mL vials (10mL), with an ultimate completion date of September 19, 2025. This contract was competitively awarded without set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on April 24, 2025, for the supply of NovoLog 100 Unit/mL vials (10 mL) with a contract value of $1,498.62. This is a firm fixed-price delivery order with an ultimate completion date of April 25, 2025, and represents a non-set-aside competitive award. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $5,186.40 to AmerisourceBergen Drug Corp for NovoLog 100 Unit/mL vials (10mL) on September 16, 2025, with completion scheduled for September 17, 2025. This firm fixed-price delivery order was awarded without set-aside designation through competitive procurement. The pharmaceutical product will be delivered to AmerisourceBergen's corporate headquarters location in Conshohocken, Pennsylvania, supporting the agency's medical supply...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,735.26 to AmerisourceBergen Drug Corp for NovoLog 100 Unit/mL vials (10 mL) on July 14, 2025, with an ultimate completion date of July 15, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded to the prime contractor. The place of performance is listed as AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen...
- The Defense Logistics Agency awarded a $1,944.90 delivery order to AmerisourceBergen Drug Corp for NovoLog 100 Unit/mL vials (10 mL) on July 18, 2025, with completion scheduled for July 21, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical federal vendor specializing in medical supply chain support for military and veteran healthcare...
- The Defense Logistics Agency awarded a delivery order valued at $8,616.75 to AmerisourceBergen Drug Corp for NovoLog 100 Unit/mL vials (10mL) on September 26, 2025, with an ultimate completion date of September 29, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a child order under a larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a $2,540.18 delivery order to AmerisourceBergen Drug Corp on October 27, 2025, for the supply of NovoLog 100 Unit/mL vials (10 mL). The contract, which employs firm fixed-price terms, is scheduled for completion by October 28, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This is a non-set-aside competitive award, reflecting AmerisourceBergen's demonstrated capability to meet federal pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $4,819.02 to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of NovoLog 100 Unit/mL vials (10 mL). The contract, classified as a firm fixed price delivery order with an ultimate completion date of August 18, 2025, will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This award was made through open competition with no set-aside designation. This delivery order is issued...
- SPE2DR25D1104Indefinite Delivery Contract
- SPE2DR25D1104-SPE2DR26FK292Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $3,105.50 to AmerisourceBergen Drug Corp for NovoLog 100 Unit/mL vials (10 mL) on November 10, 2025, with an ultimate completion date of November 12, 2025. This is a firm fixed price, non-set-aside contract for delivery to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. This delivery order represents a routine pharmaceutical procurement supporting military healthcare operations. AmerisourceBergen, as a major pharmaceutical distributor and critical vendor for federal medical supply chains, regularly fulfills such orders for insulin and other essential medications across the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The competitively awarded IDC vehicle enables flexible pharmaceutical sourcing to meet the comprehensive medical needs of military personnel and veterans globally, with NovoLog being a standard insulin product used in military medical facilities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.1k | 11/10/25 |